U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Refractory precursor T-lymphoblastic lymphoma/leukemia

MedGen UID:
167728
•Concept ID:
C0854859
•
Neoplastic Process
Synonyms: Precursor T Lymphoblastic Lymphoma/Leukemia Refractory; precursor T lymphoblastic lymphoma/leukemia refractory; Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia; refractory precursor T-lymphoblastic lymphoma/leukemia; Refractory T Lymphoblastic Leukemia/Lymphoma; refractory T lymphoblastic leukemia/lymphoma; Refractory T-Lymphoblastic Leukemia/Lymphoma
 
Monarch Initiative: MONDO:0004404

Definition

T-lymphoblastic leukemia/lymphoma that is resistant to treatment [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRefractory precursor T-lymphoblastic lymphoma/leukemia

Recent clinical studies

Etiology

Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia.
Guan W, Jing Y, Dou L, Wang M, Xiao Y, Yu L
Leuk Lymphoma 2020 Apr;61(4):855-861. Epub 2019 Nov 22 doi: 10.1080/10428194.2019.1691195. PMID: 31755348

Diagnosis

T-Lymphoblastic Leukemia/Lymphoma and Thymoma: A Case Report and Review of the Literature of a Rare Association.
Mizrahi N, Kugler E, Hayman L, Yeshurun M, Grossman A, Raanani P, Wolach O
Acta Haematol 2022;145(1):106-111. Epub 2021 Sep 17 doi: 10.1159/000519033. PMID: 34537764

Therapy

Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia.
Guan W, Jing Y, Dou L, Wang M, Xiao Y, Yu L
Leuk Lymphoma 2020 Apr;61(4):855-861. Epub 2019 Nov 22 doi: 10.1080/10428194.2019.1691195. PMID: 31755348

Prognosis

T-Lymphoblastic Leukemia/Lymphoma and Thymoma: A Case Report and Review of the Literature of a Rare Association.
Mizrahi N, Kugler E, Hayman L, Yeshurun M, Grossman A, Raanani P, Wolach O
Acta Haematol 2022;145(1):106-111. Epub 2021 Sep 17 doi: 10.1159/000519033. PMID: 34537764
Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia.
Guan W, Jing Y, Dou L, Wang M, Xiao Y, Yu L
Leuk Lymphoma 2020 Apr;61(4):855-861. Epub 2019 Nov 22 doi: 10.1080/10428194.2019.1691195. PMID: 31755348

Clinical prediction guides

Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia.
Guan W, Jing Y, Dou L, Wang M, Xiao Y, Yu L
Leuk Lymphoma 2020 Apr;61(4):855-861. Epub 2019 Nov 22 doi: 10.1080/10428194.2019.1691195. PMID: 31755348

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...